GlassScriptPhysician profile
Eric Lindsley
NPI 1427586742
$1,491.69
in general payments reported to CMS, 2019-2025
14 companies · $460 in 2025
The $460 reported for 2025 was more than what 77% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $16.91 · 2022: $99.60 · 2023: $566 · 2024: $350 · 2025: $460.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190 · Travel and Lodging: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.94 |
| Travel and Lodging | $185.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $467.84 | 2023-2025 | |
| Trice Medical, INC. | $368.07 | 2023-2025 | |
| Spr Therapeutics, INC | $365.80 | 2023 | Sprint Pns System |
| Abbvie INC. | $102.89 | 2023-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $44.97 | 2022 | |
| Axsome Therapeutics, INC. | $21.83 | 2024 | Auvelity |
| Vertex Pharmaceuticals Incorporated | $17.45 | 2025 | |
| Novo Nordisk INC | $16.94 | 2022 | |
| Saol Therapeutics INC. | $16.91 | 2020 | |
| Lilly USA, LLC | $16.60 | 2025 | Mounjaro, Zepbound |
| Depuy Synthes Sales INC. | $14.70 | 2023 | Monovisc, Orthovisc |
| Sanofi-Aventis U.S. LLC | $14.09 | 2022 | |
| Glaxosmithkline, LLC. | $11.85 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.75 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Lindsley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.